The IL-1β Antibody Gevokizumab Limits Cardiac Remodeling and Coronary Dysfunction in Rats With Heart Failure

by Najah Harouki, BS, Lionel Nicol, PhD, Isabelle Remy-Jouet, PhD, Jean-Paul Henry, BS, Anais Dumesnil, BS, Annie Lejeune, BS, Sylvanie Renet, BS, Francesca Golding, BS, Zoubir Djerada, PhD, Didier Wecker, PhD, Virginie Bolduc, PhD, Muriel Bouly, PhD, Jerome Roussel, PhD, Vincent Richard, PhD, Paul Mulder, PhD
Published 2017-08-01